APA

Bakhashab S., Ahmed F. W., Schulten H., Bashir A., Karim S., Al-Malki A. L., Gari M. A., Abuzenadah A. M., Chaudhary A. G., Alqahtani M. H., Lary S., Ahmed F. & Weaver J. U. (20161011). Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction. : Cardiovascular diabetology.

Chicago

Bakhashab Sherin, Ahmed Fahad W, Schulten Hans-Juergen, Bashir Ayat, Karim Sajjad, Al-Malki Abdulrahman L, Gari Mamdooh A, Abuzenadah Adel M, Chaudhary Adeel G, Alqahtani Mohammed H, Lary Sahira, Ahmed Farid and Weaver Jolanta U. 20161011. Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction. : Cardiovascular diabetology.

Harvard

Bakhashab S., Ahmed F. W., Schulten H., Bashir A., Karim S., Al-Malki A. L., Gari M. A., Abuzenadah A. M., Chaudhary A. G., Alqahtani M. H., Lary S., Ahmed F. and Weaver J. U. (20161011). Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction. : Cardiovascular diabetology.

MLA

Bakhashab Sherin, Ahmed Fahad W, Schulten Hans-Juergen, Bashir Ayat, Karim Sajjad, Al-Malki Abdulrahman L, Gari Mamdooh A, Abuzenadah Adel M, Chaudhary Adeel G, Alqahtani Mohammed H, Lary Sahira, Ahmed Farid and Weaver Jolanta U. Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction. : Cardiovascular diabetology. 20161011.